Clinical trial
NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Relapsing Forms of Multiple Sclerosis Experiencing Fatigue or Sleepiness
NCT01591551 is registered in ClinicalTrials.gov with Cornerstone Health Care, PA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Relapsing Forms of Multiple Sclerosis Experiencing Fatigue or Sleepiness
- Lead sponsor
- Cornerstone Health Care, PA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 37 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.